Italia markets closed

ITCI May 2024 45.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,86000,0000 (0,00%)
Alla chiusura: 12:57PM EDT
Schermo intero
Chiusura precedente0,8600
Aperto0,8600
Denaro0,0000
Lettera0,7500
Prezzo d'esercizio45,00
Scadenza2024-05-17
Min-Max giorno0,8600 - 0,8600
Contratto - Min-MaxN/D
Volume1
Open Interest82
  • GlobeNewswire

    Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

    NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the 2023 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2023 at 1:15 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company

  • GlobeNewswire

    Intra-Cellular Therapies to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

    NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, September 12, 2023 at 12:55 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Comp

  • GlobeNewswire

    Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference

    NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023 at 1:30 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's websit